David Huntsman

Researcher

Related Research

Sarcoma

Origins and progression of childhood, adolescent and young adult (CAYA) sarcomas

In 1977, Terry Fox was diagnosed with osteosarcoma – a rare bone cancer – at just 18 years old. He lost his leg and endured 16 months of treatment before showing Canada, and the world, tha...
Read More
Endometrial Cancer

Precision Oncology for Endometrial Carcinoma Patients

Molecular testing has allowed researchers to understand that not all cancers are the same—even if they grow in the same part of the body or look similar under a microscope. This is the case with...
Read More
Rare Cancers

New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...
Read More
All Cancers

Clinician-scientists in molecular oncologic pathology

Over the last decade there has been exponential growth in our understanding of the molecular basis of cancer. This is being driven by technical advances across a broad range of disciplines, including ...
Read More
Completed

Rare Cancers

Genomics of forme fruste tumours: new vistas on cancer biology and treatment

Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...
Read More
Completed

Ovarian Cancer

Canadian ovarian cancer research consortium

Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. More than one in four women do not respond to standard first-line chemotherapy treatment — an alarming nu...
Read More

Related News & Events

TFRI News|October 28, 2025

$14.5 million will move research in sarcomas, bladder cancer and high-risk brain cancer beyond one-size-fits-all cancer care

Four research teams across Canada have received a total of $14.5 million though the 2025 Terry Fox New Frontiers Program Project Grants (PPGs), a long...

Research Highlight|December 14, 2023

BC team identifies drivers of aggressive childhood cancers and develops model to explore new treatments

A team of BC-based researchers verified two drivers of cancerous tumours caused by DICER1 syndrome and developed an animal model that will allow them ...

Research Highlight|June 22, 2023

Une nouvelle étude révèle qu’un acide aminé pourrait servir au traitement de certains cancers agressifs

Une étude conjointe menée sur trois ans par des scientifiques de l’Université McGill et de l’Université de Colombie-Britannique et financée en partie ...

Research Highlight|June 22, 2023

New study identifies amino acid to potentially treat aggressive cancers

The dietary supplement alanine has been found to be effective in the treatment of aggressive cancers in preclinical models, such as small cell carcino...

Research Highlight|August 31, 2020

New treatment possibilities for young women diagnosed with rare form of ovarian cancer

A recent finding by TFRI-funded researchers in BC may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovaria...

Research Highlight|January 15, 2020

Goundbreaking discovery could help block metastasis for two kinds of sarcomas, including the one that claimed Terry Fox

TFRI researchers have found that a family of drugs known as Class 1 HDAC inhibitors can block sarcoma metastasis in mice by hindering a cancer cell’s ...

TFRI News|June 05, 2018

Three top Canadian research teams receive $13 million to solve key cancer challenges

Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-...

Research Highlight|February 15, 2018

Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women

A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma o...

Research Highlight|May 18, 2017

B.C. team study detects rare ovarian cancer mutation in ctDNA of patients

The finding by a B.C. team studying rare and forme fruste tumours is important in that it may help to identify women at risk of relapse for the diseas...

All News & Events